Wedbush Maintains Neutral on Cerence, Raises Price Target to $32
Wedbush analyst Daniel Ives maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $25 to $32.
Related Posts
‘The Russian Foreign Ministry says a suicide attack outside Kabul airport killed at least two people and wounded 15.’ -Associated Press Tweet
https://twitter.com/AP/status/1430904400793378816
Xylem Q4 Adj. EPS $0.92 Beats $0.79 Estimate, Sales $1.51B Beat $1.41B Estimate
Xylem (NYSE:XYL) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.79 by 16.46 percent. This is a 46.03 percent increase over earnings of $0.63 per share from the same period
Kanye West’s Feud With Adidas And Gap Heats Up: What’s On The Line For Him And The Companies
In 2016, Kanye West's apparel brand Yeezy partnered with Adidas AG - ADR (OTCQX: ADDYY) for Adidas + Kanye West to manufacture footwear, apparel and accessories.